CID 46834118

Derazantinib

Structural Information

Molecular Formula
C29H29FN4O
SMILES
COCCNCCC1=CC(=CC=C1)NC2=NC=C3C[C@H](C4=CC=CC=C4C3=N2)C5=CC=CC=C5F
InChI
InChI=1S/C29H29FN4O/c1-35-16-15-31-14-13-20-7-6-8-22(17-20)33-29-32-19-21-18-26(24-10-4-5-12-27(24)30)23-9-2-3-11-25(23)28(21)34-29/h2-12,17,19,26,31H,13-16,18H2,1H3,(H,32,33,34)/t26-/m1/s1
InChIKey
KPJDVVCDVBFRMU-AREMUKBSSA-N
Compound name
(6R)-6-(2-fluorophenyl)-N-[3-[2-(2-methoxyethylamino)ethyl]phenyl]-5,6-dihydrobenzo[h]quinazolin-2-amine
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

14
References

1423
Patents

468.23254 Da
Monoisotopic Mass

5.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 469.23982 215.2
[M+Na]+ 491.22176 220.4
[M-H]- 467.22526 221.1
[M+NH4]+ 486.26636 221.0
[M+K]+ 507.19570 211.2
[M+H-H2O]+ 451.22980 200.2
[M+HCOO]- 513.23074 231.4
[M+CH3COO]- 527.24639 221.2
[M+Na-2H]- 489.20721 219.8
[M]+ 468.23199 214.1
[M]- 468.23309 214.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe